myelodysplastic syndrome

Showing NaN - NaN of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral

Completed
  • Myelodysplastic Syndrome
  • +2 more
  • Gilbert, Arizona
  • +12 more
Jun 15, 2021

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

Withdrawn
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +11 more
  • Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
  • +2 more
  • Duarte, California
  • +2 more
Nov 19, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Duarte, Lexington (PD-616)

Terminated
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Duarte, California
  • +1 more
Jul 23, 2018

Myelodysplastic Syndrome, MDS Trial in United States (pracinostat, Azacitidine, Decitabine)

Completed
  • Myelodysplastic Syndrome
  • MDS
  • Mobile, Alabama
  • +20 more
Feb 22, 2017

Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • VCL-CB01
  • Phosphate-buffered Saline (PBS)
  • Tucson, Arizona
  • +21 more
Jul 31, 2013

Myelodysplastic Syndrome Trial in United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Myelodysplastic Syndrome
  • decitabine (5-aza-2'deoxycytidine)
  • Berkeley, California
  • +23 more
Jan 22, 2013